Abstract
Rheumatoid arthritis (RA) is associated with increased cardiovascular mortality. However, cardiovascular findings are mostly subtle, and diastolic function abnormalities are one of the earliest manifestations. The aim of this study was to determine diastolic function abnormalities in RA patients and to make a reevaluation of diastolic function after 5 years of follow-up. Seventy-two RA patients (mean age: 48 ± 11 years, F/M: 62/10) without any known cardiac disease and 67 controls (mean age: 46 ± 11 years; F/M: 53/14) were recruited. Disease activity score (DAS), lipid values, and C-reactive protein (CRP) levels were determined. Left ventricular mass, isovolumetric relaxation time, mitral annular early (E), and late (A) diastolic filling rate were determined by M-mode two-dimensional color Doppler echocardiography. Mitral annular early (E′) and late (A′) diastolic velocities were also evaluated by tissue Doppler echocardiography. Twenty-four RA patients were reevaluated after 5 years of follow-up with DAS, biochemical variables, and echocardiography. Fifty five of 72 (76%) RA patients and 12 of the 67 (18%) controls had diastolic dysfunction (DD). Seven of ten patients with DD at baseline continued to have DD, whereas three did not show DD at 5 years. Six of 14 patients without DD at baseline developed DD at follow-up, while eight patients sustained normal diastolic function. Although DAS and lipid values were not altered during the course of 5 years, CRP levels decreased significantly (P < 0.05). In conclusion, RA patients have diastolic function abnormalities compared to healthy controls. Five-year follow-up of a subgroup of our patients showed that, although clinical response was unsatisfactory, cardiac function was conserved without a major deterioration. Moreover, DMARDs, such as anti-TNFα agents, do not seem to have a major adverse effect on cardiac findings in these patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Pincus T, Callahan LF (1986) Taking mortality in rheumatoid arthritis seriously-predictive markers, socioeconomic status and comorbidity. J Rheumatol 13:841–845
Mutru O, Laakso M, Isomaki H et al (1989) Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 76:71–77
Prior P, Symmons DP, Scott DL et al (1984) Cause of death in rheumatoid arthritis. Br J Rheumatol 23:92–99
Symmons DP, Jones MA, Scott DL et al (1998) Long term mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol 25:1072–1077
Wallberg-Jonsson S, Ohman ML, Dahlqvist SR (1997) Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol 24:445–451
Okada T, Shiokawa Y (1975) Cardiac lesions in collagen disease. Jpn Circ J 39:479–484
Bacon PA, Stevens RJ, Carruthers DM et al (2002) Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev 1:338–347
Wislowska M, Sypula S, Kowalik I (1998) Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker's criteria, functional index, value of Waaler-Rose titre and duration of disease. Clin Rheumatol 17:369–377
Maki-Petaja KM, Hall FC, Booth AD et al (2006) Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 114:1185–1192
Choi HK, Hernan MA, Seeger JD et al (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359:1173–1177
Arnett FC, Edworthy SM, Bloch DA et al (1998) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
Oh JK, Hatle L, Tajik AJ et al (2006) Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol 47:500–506
Nishimura RA, Tajik AJ (1997) Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol 30:8–18
Nagueh SF, Middleton KJ, Kopelen HA et al (1997) Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527–1533
Arslan S, Bozkurt E, Sari RA et al (2006) Use of tissue Doppler and its comparison with other conventional Doppler techniques in the assessment of diastolic functions in patients with active rheumatoid arthritis. Rheumatol Int 26:229–233
Birdane A, Korkmaz C, Ata N et al (2007) Tissue Doppler imaging in the evaluation of the left and right ventricular diastolic functions in rheumatoid arthritis. Echocardiography 24:485–493
Pasceri V, Yeh ET (1999) A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation 100:2124–2126
Krishnan E, Lingala VB, Singh G (2004) Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 110:1774–1779
Kroot EJ, van Leeuwen MA, van Rijswijk MH et al (2000) No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. Ann Rheum Dis 59:954–958
Lindqvist E, Eberhardt K (1999) Mortality in rheumatoid arthritis patients with disease onset in the 1980s. Ann Rheum Dis 58:11–14
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yazici, D., Tokay, S., Aydin, S. et al. Echocardiographic evaluation of cardiac diastolic function in patients with rheumatoid arthritis: 5 years of follow-up. Clin Rheumatol 27, 647–650 (2008). https://doi.org/10.1007/s10067-007-0820-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-007-0820-x